Erythropoietin increases hemoglobin during radiation therapy for cervical cancer

International Journal of Radiation Oncology, Biology, Physics

Volumn 29, Issue 5, 1994, Pages 1079-1084

  Dusenbery, Kathryn E ^a   McGuire, Warren A ^a   Holt, Penne J ^a   Carson, Linda F ^a   Fowler, Jeffrey M ^a   Twiggs, Leo B ^a   Potish, Roger A ^a  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

Anemia; Cervix cancer; Erythropoietin (r HuEPO); Radiation therapy (RT)

Indexed keywords

CISPLATIN; FERROUS SULFATE; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; RETICULOCYTOSIS; SUBCUTANEOUS DRUG ADMINISTRATION; UTERINE CERVIX CANCER;

ADULT; AGED; ANEMIA; ERYTHROPOIETIN; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; MIDDLE AGED; PILOT PROJECTS; QUALITY OF LIFE; RADIATION INJURIES; RECOMBINANT PROTEINS; RETICULOCYTES; UTERINE CERVICAL NEOPLASMS;

EID: 0028025601     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(94)90403-0     Document Type: Article

References (40)

1. Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer
2. Association between transfusion of whole blood and recurrence of cancer
3. The significance of anemia in clinical RT
4. Definitive evidence for hypoxic cells influencing cure in cancer therapy
5. Variables associated with postoperative deep venous thrombosis: A prospective study of 411 gynecology patients and creation of a prognostic model
6. Thromboemolism in patients with gyn tumors: Risk factors, natural history, and prophylaxis
7. Prevention of postoperative venous thromboemolism by external pneumatic calf compression in patients with gynecologic malignancy
8. Exposure of patients to human immunodeficiency virus through the transfusion of blood products that test antibody negative
9. The declining risk of posttransfusion Hepatitis C virus infection
10. Measuring quality of life in cancer patients
11. Pretreatment surgical staging in cervical carcinoma: Therapeutic efficacy of pelvic lymph node resection
12. The distribution of active bone marrow in the adult
13. The Influence of anemia on the results of radiotherapy in carcinoma of the cervix
14. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin
15. Recombinant human erythropoietin for patients with aids treated with zidovudine
16. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: Results of a retrospective study of 386 patients
17. Costs and benefits of adjuvant therapy in breast cancer: A quality-adjusted survival analysis
18. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy
19. Assessment of the quality of life of patients with advanced cancer
20. Erythropoietin for chemotherapy patient refusing blood transfusion
21. Anemia as a prognostic factor in cancer of the cervix
22. Recombinant human erythropoietin in patients with ovarian carcinoma and anaemia secondary to cisplatin and carboplatin chemotherapy: Preliminary results
23. Pretreatment prognostic factors in carcinoma of the uterine cervix: A multivariable analysis of the effect of age, stage, histology and blood counts on survival
24. Treatment of acute postoperative anemia with recombinant human erythropoietin
25. Blood transfusion in patients receiving radical radiotherapy: A reappraisal
26. Recombinant human erythropoietin treatment in pre-dialysis patients: A double blind placebo-controlled study
27. Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration
28. Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix
29. Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients
30. RT and the role of red blood cell transfusion
31. The morbidity and utility of periaortic radiotherapy in cervical carcinoma
32. Effect of cis-platinum on tolerance to RT in advanced cervical cancer
33. Therapeutic implications of the natural history of advanced cervical cancer as defined by pretreatment surgical staging
34. The effect of anemia on the radiotherapy results of the uterine cervix cancer
35. Immune consequences of blood transfusion in the surgical patient
36. Factors affecting survival in over 500 patients with stage II carcinoma of the cervix
37. Association of Hemoglobin Levels Before and During Radiotherapy with Prognosis in Uterine Cervix Cancer1
38. Effect of subcutaneous recombinanterythropoietin in cancer patients receiving radiotherapy: Preliminary results of a randomized, open-labeled, phase II trial
39. Blood transfusions as an immunomodulator-A review
40. Perioperative blood transfusions and cancer recurrence